Induction of autophagic cell death and radiosensitization by the pharmacological inhibition of nuclear factor-kappa B activation in human glioma cell lines

Journal of Neurosurgery
Yoshifumi TsuboiShunro Endo

Abstract

The intrinsic radioresistance of certain cancer cells may be closely associated with the constitutive activation of nuclear factor-kappa B (NF-kappaB) activity, which may lead to protection from apoptosis. Recently, nonapoptotic cell death, or autophagy, has been revealed as a novel response of cancer cells to ionizing radiation. In the present study, the authors analyzed the effect of pitavastatin as a potential inhibitor of NF-kappaB activation on the radiosensitivity of A172, U87, and U251 human glioma cell lines. The pharmacological inhibition of NF-kappaB activation was achieved using pitavastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Growth and radiosensitivity assays were performed using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Hoechst 33258 staining, supravital acridine orange staining, and electron microscopy were performed utilizing 3 glioma cell lines with or without pitavastatin pretreatment to identify apoptosis or autophagy after irradiation. The growth of these 3 glioma cell lines was not significantly inhibited by pitavastatin at a concentration of up to 1 microM. Treatment with 0.1 microM of pitavastatin enhanced radiation-induced cell death in all ...Continue Reading

References

Aug 1, 1991·The Journal of Clinical Investigation·M A BrachD Kufe
Mar 28, 1998·The Journal of Biological Chemistry·T Noda, Y Ohsumi
Oct 21, 1998·Oncogene·S L CampbellC J Der
Jul 8, 1999·Proceedings of the National Academy of Sciences of the United States of America·S RaoK Keyomarsi
Nov 24, 1999·Journal of the National Cancer Institute·A Dritschilo
May 23, 2000·Annals of Medicine·S BellostaA Corsini
Dec 2, 2000·Science·D J Klionsky, S D Emr
Feb 13, 2001·The Journal of Clinical Investigation·Y Yamamoto, R B Gaynor
Apr 24, 2001·International Journal of Radiation Oncology, Biology, Physics·S M RussoJ C Cusack
Aug 22, 2003·Cardiovascular Drug Reviews·Kouji KajinamiYasushi Saito
Jan 1, 1997·Apoptosis : an International Journal on Programmed Cell Death·K D Held
Jan 10, 2004·Cell Death and Differentiation·T KanzawaS Kondo
Feb 27, 2004·Oncogene·Damodaran ChendilMansoor M Ahmed
May 10, 2005·Blood·Raffaella AvellinoMaria Fiammetta Romano
Sep 9, 2005·Nature Reviews. Cancer·Yasuko KondoSeiji Kondo
Jul 22, 2006·The Journal of Biological Chemistry·Mojgan Djavaheri-MergnyPatrice Codogno
Sep 5, 2006·Cancer Research·Michael J CampbellChristopher C Benz
Nov 7, 2006·Journal of Cardiovascular Pharmacology·Akiko TsujimotoHisayoshi Fujiwara
Feb 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kwang Seok AhnBharat B Aggarwal
May 9, 2007·Cytokine & Growth Factor Reviews·Gutian Xiao

❮ Previous
Next ❯

Citations

Feb 9, 2011·Medical Oncology·Hong LinJinxiang Cheng
Jun 29, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xiaoli LiHong Zhou
Sep 22, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Yohei MineharuMaria G Castro
Dec 17, 2009·The Journal of Biological Chemistry·Julie M LoweAlbert J Fornace
Apr 5, 2013·World Journal of Gastroenterology : WJG·Xue-Li PangBo Zhang
Jan 18, 2014·Journal of Translational Medicine·Pengfei JiangSantosh Kesari
Aug 18, 2012·International Journal of Cell Biology·Antero SalminenKai Kaarniranta
Oct 1, 2011·Chinese Journal of Cancer·Jun-Lin LiXia Fan
Feb 19, 2016·British Journal of Cancer·Michael I KoukourakisAlexandra Giatromanolaki
Nov 17, 2015·International Journal of Molecular Sciences·Byeong Mo KimYonggeun Hong
Oct 16, 2013·Critical Reviews in Oncology/hematology·Suna ZhouJun Liang
Mar 19, 2013·Biochemical and Biophysical Research Communications·Sung Youl KimJeen-Woo Park
Aug 30, 2011·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Maja MisirkicVladimir Trajkovic
Jun 23, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·David A GewirtzEden N Wilson
Apr 30, 2016·Oxidative Medicine and Cellular Longevity·Doaa M BadrSamia A Shouman
May 9, 2012·The International Journal of Biochemistry & Cell Biology·Min-Jin LimJie-Young Song
Mar 25, 2011·Nature Reviews. Cancer·Adrian C BeggConchita Vens
Jun 26, 2009·Critical Reviews in Clinical Laboratory Sciences·Alfred J Meijer, Patrice Codogno
Jan 14, 2020·Journal of Oncology·Yunseo WooYu-Jin Jung
Mar 1, 2012·Expert Review of Molecular Diagnostics·Yu-Chang LiuJeng-Jong Hwang
May 23, 2012·International Journal of Oncology·Jérôme KroonenPierre A Robe
Sep 21, 2018·Histochemistry and Cell Biology·Yoshikazu KuwaharaManabu Fukumoto

❮ Previous
Next ❯

Methods Mentioned

BETA
antisense oligodeoxynucleotide
fluorescence microscopy
electron microscopy
Protein Assay
Assay
transmission electron microscopy

Related Concepts

Related Feeds

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis